DYAX CORP.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 68187
 
  
 
C07K PEPTIDES 6870
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 37130
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 31175
 
  
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 272
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1782
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 14111
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 792
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 6234
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 544

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0037,664 PLASMA KALLIKREIN BINDING PROTEINSSep 15, 17Feb 08, 18[A61K, C07K]
2018/0037,665 PLASMA KALLIKREIN BINDING PROTEINSSep 15, 17Feb 08, 18[A61K, C07K]
2018/0037,666 PLASMA KALLIKREIN BINDING PROTEINSSep 15, 17Feb 08, 18[A61K, C07K]
2018/0002,447 PLASMA KALLIKREIN BINDING PROTEINSSep 15, 17Jan 04, 18[A61K, C07K]
2018/0002,448 PLASMA KALLIKREIN BINDING PROTEINSSep 15, 17Jan 04, 18[A61K, C07K]
2018/0002,449 PLASMA KALLIKREIN BINDING PROTEINSSep 15, 17Jan 04, 18[A61K, C07K]
2017/0369,557 NOVEL METHODS OF CONSTRUCTING LIBRARIES COMPRISING DISPLAYED AND/OR EXPRESSED MEMBERS OF A DIVERSE FAMILY OF PEPTIDES, POLYPEPTIDES OR PROTEINS AND THE NOVEL LIBRARIESJun 02, 17Dec 28, 17[C12N, C40B, C07K]
2017/0240,887 LIGAND SCREENING AND DISCOVERYJan 10, 17Aug 24, 17[C12N]
2016/0355,571 LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR1, CDR2, AND CDR3 AND NOVEL LC CDR1, CDR2, AND CDR3 DESIGNSJun 08, 16Dec 08, 16[C40B, C07K]
2016/0304,608 FC RECEPTOR BINDING PROTEINSApr 27, 16Oct 20, 16[A61K, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9873957 Libraries of genetic packages comprising novel HC CDR3 designsMar 13, 09Jan 23, 18[C40B, C07K]
9862768 Methods of producing antibodies to neonatal Fc receptor (FcRn)Apr 27, 16Jan 09, 18[A61K, G01N, C07K]
9845340 Peptides that specifically bind HGF receptor (cMet) and uses thereofFeb 19, 15Dec 19, 17[A61K, B82Y, C07K]
9803028 Antibodies against phosphorylcholineAug 08, 12Oct 31, 17[A61K, C07K]
9803190 Focused libraries of genetic packagesJan 30, 13Oct 31, 17[C12N, C40B, C07K]
9796786 Antibodies binding to phosphorylcholine (PC) and/or PC conjugatesAug 08, 12Oct 24, 17[A61K, C07K]
9757437 Kallikrein inhibitors and anti-thrombolytic agents and uses thereofMay 06, 14Sep 12, 17[A61K]
9683028 Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel librariesDec 01, 14Jun 20, 17[C12N, C40B, C07K]
9670481 Display library processOct 08, 13Jun 06, 17[B03C, C12N, G01N, C40B]
9629934 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapySep 05, 13Apr 25, 17[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0222,109 FC RECEPTOR BINDING PROTEINSAbandonedDec 29, 15Aug 04, 16[C07K]
2016/0222,110 FC RECEPTOR BINDING PROTEINSAbandonedDec 29, 15Aug 04, 16[A61K, G01N, C07K]
2016/0222,111 FC RECEPTOR BINDING PROTEINSAbandonedDec 30, 15Aug 04, 16[C07K]
2016/0222,112 FC RECEPTOR BINDING PROTEINSAbandonedDec 30, 15Aug 04, 16[C07K]
9403910 Polynucleotides encoding an actriib antibodyWithdrawnMar 14, 13Aug 02, 16[A61K, C07K]
2016/0194,397 FC RECEPTOR BINDING PROTEINSAbandonedDec 31, 15Jul 07, 16[C07K]
2015/0374,843 MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONSAbandonedApr 17, 15Dec 31, 15[A61K]
2015/0368,359 COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISORDERSAbandonedJun 19, 15Dec 24, 15[A61K, C07K]
2015/0023,978 ANTI MIF ANTIBODIESAbandonedJan 17, 14Jan 22, 15[C07K]
2014/0199,324 EVALUATING PROTEIN EXPRESSION IN PATIENT STRATIFICATION AND OTHER THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC METHODS FOR CANCERAbandonedMar 23, 12Jul 17, 14[G01N]
8663629 Kallikrein-binding “kunitz domain” proteins and analogues thereofExpiredAug 09, 12Mar 04, 14[C07H, A61K, A01N, C12Q, C12P]
2013/0244,890 EVALUATING MMP EXPRESSION IN PATIENT STRATIFICATION AND OTHER THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC METHODS FOR CANCERAbandonedApr 24, 12Sep 19, 13[C12Q, G01N]
2013/0189,944 TRACKING AND REPORTING INFORMATION CHARACTERIZING ATTACKS CAUSED BY A DISEASEAbandonedJan 16, 13Jul 25, 13[G08B, H04W]
8431359 Nucleic acids encoding polypeptide inhibitors of human plasmin derived from the Kunitz domainsExpiredMar 18, 05Apr 30, 13[C12P]
2013/0045,218 FC RECEPTOR BINDING PROTEINSAbandonedAug 13, 12Feb 21, 13[A61K, G01N, A61P, C07K]
2012/0322,744 POLY-PEGYLATED PROTEASE INHIBITORSAbandonedMay 03, 12Dec 20, 12[A61K, A61P, C07K]
8283321 Kallikrein-binding “Kunitz domain” proteins and analogues thereofExpiredOct 16, 09Oct 09, 12[A61K, C12Q, C12P]
8183008 Evaluating MMP expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancerExpiredDec 17, 08May 22, 12[C12Q]
2012/0027,686 HK1-BINDING PROTEINSAbandonedJul 28, 11Feb 02, 12[A61K, C12N, G01N, A61P, C40B]
2011/0300,157 METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINSAbandonedAug 01, 11Dec 08, 11[A61K, A61P, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.